Risk factors of infection of totally implantable venous access port: A retrospective study

被引:2
|
作者
Guan, Xiaonan [1 ]
Yan, He [2 ]
Zhang, Jianjun [1 ]
Li, Yanbing [1 ]
Zhou, Yiming [2 ]
机构
[1] Capital Med Univ, Beijing Chaoyang Hosp, Ctr Cardiol, Beijing, Peoples R China
[2] Capital Med Univ, Beijing Chaoyang Hosp, Ctr Intervent Dept, 5 Jingyuan Rd, Beijing 100043, Peoples R China
来源
JOURNAL OF VASCULAR ACCESS | 2023年 / 24卷 / 06期
关键词
Totally implantable venous access port; perioperative infection; complication; cancer patient; antibiotics; CLINICAL-PRACTICE; ANTIBIOTIC-PROPHYLAXIS; PRACTICE GUIDELINE; DEVICE PLACEMENT; CANCER; COMPLICATIONS; CATHETER; DIAGNOSIS; SOCIETY; SYSTEMS;
D O I
10.1177/11297298221085230
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background: Infection is the most frequent complication associated with the use of totally implantable venous access port (TIVAP). This retrospective study was conducted to determine the risk factors affecting TIVAP-related infection. Methods: A total of 1406 patients implanted with TIVAP at our center were included in this retrospective study. Incidence of perioperative infection, patient characteristics and bacteriologic data were retrieved and analyzed. Univariable analyses and multiple logistic regression analyses were used to determine the risk factors. Results: Overall, 72 (5.1%) patients had perioperative infection, and TIVAP was finally removed from 12 (0.85%) patients. There was significantly more hematologic malignancy in the infection group, compared to the non-infection group. Patients with chemotherapy and infection within 30 days before operation also had more infections. There were more inpatients in the infection group than in the non-infection group. The rate of hematoma was higher in the infected patients. Multivariate logistic analysis revealed that hematoma (OR 5.695, p < 0.001), preoperative hospital stay (> 14d) (OR 2.945, p < 0.001), history of chemotherapy (OR 2.628, p = 0.002), history of infection (within 30 days) (OR 4.325, p < 0.001) were independent risk factor for infection. Conclusions: This study demonstrated that hematoma, preoperative hospital stay (> 14d), history of chemotherapy and history of infection (within 30 days) are independent risk factor for all patients.
引用
收藏
页码:1340 / 1348
页数:9
相关论文
共 50 条
  • [41] Port-exposure management of totally implantable venous access ports: A case report
    Liu, Chunqin
    Liu, Xiaohua
    Zhao, Shunying
    Li, Weifeng
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (04) : 1064 - 1069
  • [42] Totally implantable venous access port infection caused by Staphylococcus pseudintermedius: Possible transmission from a companion dog to a human
    Nomoto, Hidetoshi
    Kutsuna, Satoshi
    Nakamura, Keiji
    Nakamoto, Takato
    Shimomura, Akira
    Hirakawa, Takanori
    Kinoshita, Noriko
    Hayakawa, Kayoko
    Nagashima, Maki
    Ohmagari, Norio
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (12) : 1305 - 1308
  • [43] Accessing totally implantable venous access systems on the day of placement does not significantly increase the risk of infection
    Young, Shamar J.
    Young, Linda J.
    Vogel, Jeffery
    Sutkowski, Raymond
    Venkataperumal, Satish
    Journal of Vascular Access, 2016, 17 (03): : 261 - 264
  • [44] Totally implantable venous access port insertion via open Seldinger approach of the internal jugular vein—a retrospective risk stratification of 500 consecutive patients
    Felix Becker
    Lennart A. Wurche
    Martina Darscht
    Andreas Pascher
    Benjamin Struecker
    Langenbeck's Archives of Surgery, 2021, 406 : 903 - 910
  • [45] A TECHNIQUE FOR PLACEMENT OF A TOTALLY IMPLANTABLE CENTRAL VENOUS PORT
    GILCHRIST, BF
    NOVAK, Z
    CLINICAL PEDIATRICS, 1993, 32 (05) : 313 - 314
  • [46] Analysis of risk factors for implantable venous access port catheter fracture with internal jugular vein
    Ai, Ning
    Li, Li
    Yin, Fenghua
    Li, Zhigang
    Geng, Cuizhi
    Yang, Guang
    ANNALS OF PALLIATIVE MEDICINE, 2020, 9 (01) : 30 - 36
  • [47] Totally implantable central venous access ports
    Jarosz, Jerzy
    Krzakowski, Maciej
    Dworzanski, Kazimierz
    Czech, Irena
    Filipczyk-Cisarz, Emilia
    Glogowska, Iwona
    Goraj, Elwira
    Gozdz, Stanislaw
    Jagiello-Gruszfeld, Agnieszka
    Kasalik, Grzegorz
    Komorowski, Andrzej
    Kosinski, Boguslaw
    Les, Jaroslaw
    Mankowski, Przemyslaw
    Matuszewska, Katarzyna
    Misiak, Malgorzata
    Mlynarski, Rafal
    Rajchert, Lukasz
    Rolski, Janusz
    Rubach, Maryna
    Sienkowska-Magon, Monika
    Sierko, Ewa
    Sobanska, Danuta
    Sobolewski, Bartosz
    Tujakowski, Jerzy
    Wojtukiewicz, Marek
    ONCOLOGY IN CLINICAL PRACTICE, 2006, 2 (01): : 40 - 48
  • [48] Totally implantable venous systems (PORT) and quality of life
    Varetto, A
    Salvatico, F
    Ottaviani, B
    Fonzo, D
    Capello, C
    Milanesi, IC
    Satolli, MA
    Sandrucci, S
    Torta, R
    ANNALS OF ONCOLOGY, 2000, 11 : 29 - 29
  • [49] Update on totally implantable venous access devices
    Zaghal, Ahmad
    Khalife, Mohamed
    Mukherji, Deborah
    El Majzoub, Nadim
    Shamseddine, Ali
    Hoballah, Jamal
    Marangoni, Gabriele
    Faraj, Walid
    SURGICAL ONCOLOGY-OXFORD, 2012, 21 (03): : 207 - 215
  • [50] Totally implantable venous access devices: evaluation of complications and a prospective comparative study of two different port systems
    Hartkamp, A
    van Boxtel, AJH
    Zonnenberg, BA
    Witteveen, PO
    NETHERLANDS JOURNAL OF MEDICINE, 2000, 57 (06): : 215 - 223